Page last updated: 2024-10-25

desipramine and Cardiovascular Diseases

desipramine has been researched along with Cardiovascular Diseases in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Depression is associated with medical comorbidities, particularly cardiovascular disease."1.38Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor. ( Bhatnagar, S; Grigoriadis, D; McFadden, KV; Valentino, RJ; Wood, SK, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wood, SK1
McFadden, KV1
Grigoriadis, D1
Bhatnagar, S1
Valentino, RJ1

Other Studies

1 other study available for desipramine and Cardiovascular Diseases

ArticleYear
Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor.
    Psychopharmacology, 2012, Volume: 222, Issue:2

    Topics: Animals; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Corticotropin-Releasing Hormone;

2012